Evista and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported as a side effect among people who take Evista (raloxifene hydrochloride), especially for people who are female, 60+ old, also take Synthroid, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Evista. It is created by eHealthMe based on reports of 25,442 people who have side effects when taking Evista from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,129 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.

On Jul, 19, 2026

25,442 people reported to have side effects when taking Evista.
Among them, 18 people (0.07%) have Common peroneal nerve dysfunction.

Could Evista cause Common peroneal nerve dysfunction?

Among these 18 people:

What is the gender of people who have Common peroneal nerve dysfunction when taking Evista? *

female: 94.44 %
male: 5.56 %

What is the age of people who have Common peroneal nerve dysfunction when taking Evista? *

What are other drugs people take besides Evista? *

What are other side effects people have besides Common peroneal nerve dysfunction? *

Joint Pain: 13 people, 72.22%
Fall: 12 people, 66.67%
Hypoaesthesia (reduced sense of touch or sensation): 11 people, 61.11%
Weakness: 10 people, 55.56%
Pain: 10 people, 55.56%
Pain In Extremity: 9 people, 50.00%
Dizziness: 9 people, 50.00%
Fatigue (feeling of tiredness): 9 people, 50.00%
Oedema Peripheral (superficial swelling): 7 people, 38.89%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 38.89%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 27.78%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 16.67%
Breast Cancer: 3 people, 16.67%
Arrhythmias (irregular heartbeat): 2 people, 11.11%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 11.11%
Dry Eyes (lack of adequate tears): 2 people, 11.11%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 11.11%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 11.11%
Bronchial Hyperreactivity: 2 people, 11.11%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evista:

Evista (25,891 reports)

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (651 drugs)

Browse all the conditions that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (1,129 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raloxifene hydrochloride (the active ingredients of Evista) and Evista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.